Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cabaletta Bio
Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
November 06, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
October 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
October 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
September 19, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
August 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
August 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
July 24, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
May 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Proposed Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
May 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
May 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
May 01, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 25, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 13, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
March 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces $35 Million Offering
December 08, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces CABA-201, a Newly Designed CD19-Targeting CAR T Cell Therapy Engineered to Address a Broad Range of Autoimmune Diseases
October 11, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
October 06, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.